Recap: Amryt Pharma Q4 Earnings

Amryt Pharma AMYT reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Amryt Pharma beat estimated earnings by 53.33%, reporting an EPS of $-0.07 versus an estimate of $-0.15.

Revenue was up $12.31 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 6.67% increase in the share price the next day.

Here's a look at Amryt Pharma's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.17	0.19	0.13	-0.34
EPS Actual	-0.07	-0.04	-0.09	-0.28
Revenue Estimate	52.78M	50.49M	46.15M	41.97M
Revenue Actual	56.52M	62.76M	48.43M	42.52M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.